Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia. 1993

R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
Department of Medicine, University of California at San Francisco 94143-0854.

Pneumocystis carinii pneumonia (PCP) remains the most common lethal opportunistic pulmonary infection in patients infected with the human immunodeficiency virus (HIV). Although the use of prophylactic inhaled pentamidine has effectively reduced the frequency of primary and recurrent episodes of PCP, the aerosolization of pentamidine may have altered the localization of active PCP, resulting in more upper lobe disease. The distribution of disease may have also affected the diagnostic accuracy of standard bronchoalveolar lavage of the middle lobe, with a reduction in sensitivity from about 90 to 65%. In retrospective surveys of patients from our institution, Steiger and Fahy found that pooled multiple-lobe radiographic site-directed bronchoalveolar lavage resulted in diagnostic sensitivities of 91 and 100%, respectively. We performed a follow-up prospective study of 38 consecutive patients on aerosolized pentamidine in whom we lavaged both the middle lobe and an upper lobe. We found that bilobar lavage including routine lavage of an upper lobe increases the diagnostic sensitivity of bronchoalveolar lavage alone to 95% compared with 65% if lavage is performed only in the middle lobe (p < 0.05). Radiographic studies demonstrate a concordant increase in exclusive or predominant upper lobe disease in patients on aerosolized pentamidine, but our results indicate that PCP is recovered more frequently from the upper lobe regardless of the radiographic appearance. We conclude that all patients on prophylactic inhaled pentamidine should undergo bilobar lavage with the inclusion of an upper lobe in the initial evaluation of possible PCP. The diagnostic sensitivity of 95% makes bilobar bronchoalveolar lavage an acceptable sole initial diagnostic modality without the need for initial transbronchial lung biopsy.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
March 1994, Chest,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
March 1987, Journal of clinical pathology,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
January 2001, Acta cytologica,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
June 1991, Australian and New Zealand journal of medicine,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
February 1983, British journal of experimental pathology,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
May 1991, The American review of respiratory disease,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
November 1996, Mayo Clinic proceedings,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
January 1985, Pediatric infectious disease,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
September 1985, Nihon Kyobu Shikkan Gakkai zasshi,
R C Yung, and A B Weinacker, and D J Steiger, and T R Miller, and E J Stern, and C J Salmon, and D N Chernoff, and M G Luistro, and S Kuntz, and J A Golden
March 1996, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!